Related Experiment Videos
Pharmacomechanical coupling: the membranes talk to the crossbridges
A P Somlyo1, T Kitazawa, S Kobayashi
1Department of Physiology, University of Virginia School of Medicine, Charlottesville 22908.
Advances in Experimental Medicine and Biology
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Smooth muscle of telokin-deficient mice exhibits increased sensitivity to Ca2+ and decreased cGMP-induced relaxation.
Proceedings of the National Academy of Sciences of the United States of America·2006
LPP expression during in vitro smooth muscle differentiation and stent-induced vascular injury.
Circulation research·2006
A system for acquiring simultaneous electron energy-loss and X-ray spectrum-images.
Journal of microscopy·2004
Improved precision of quantitating calcium in biological electron probe analysis.
Journal of microscopy·2001
Regulation by GDI of RhoA/Rho-kinase-induced Ca2+ sensitization of smooth muscle myosin II.
American journal of physiology. Cell physiology·2001
Nucleoskeletal Proteins in Early Embryogenesis.
Advances in experimental medicine and biology·2026
Nuclear Dynamics and Its Timing Regulation Revealed by Live-Cell Imaging.
Advances in experimental medicine and biology·2026
Histone Modifications in Mammalian Early Embryos.
Advances in experimental medicine and biology·2026
Oocyte Kinetochores at the Nexus of Meiotic Drive and Segregation Fidelity.
Advances in experimental medicine and biology·2026
Asymmetric Chromosome Establishment and Segregation During Germline Stem Cell Division.
Advances in experimental medicine and biology·2026
Non-random Sister Chromatid Segregation Mediated by Ribosomal DNA in Drosophila Male Germline Stem Cells.
Advances in experimental medicine and biology·2026
Oral vs. Subcutaneous Semaglutide for Obesity Treatment: A Systematic Review of Efficacy, Safety, and Patient-Oriented Outcomes.
Pharmaceuticals (Basel, Switzerland)·2026
Development of a PK/PD-Efficacy Modeling Framework for Covalent Inhibitors.
Pharmaceuticals (Basel, Switzerland)·2026
Novel Roles of Urokinase- and Tissue-Type Plasminogen Activators in Substance Use Disorders: A Narrative Review of Molecular Mechanisms and Translational Perspectives.
International journal of molecular sciences·2026
New and emerging pharmacotherapeutic options for the treatment of pediatric focal epilepsies.
Expert opinion on pharmacotherapy·2026